The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives. The US Food and Drug Administration's Office of Generic Drugs (OGD) and ...
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing. Scaling up the manufacture of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results